[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1065572, "exercisedValue": 0, "unexercisedValue": 341267}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "age": 61, "title": "President & COO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 777048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 747017, "exercisedValue": 30004, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 767825, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 2597639, "exercisedValue": 0, "unexercisedValue": 1357712}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.21, "open": 7.3, "dayLow": 7.19, "dayHigh": 7.535, "regularMarketPreviousClose": 7.21, "regularMarketOpen": 7.3, "regularMarketDayLow": 7.19, "regularMarketDayHigh": 7.535, "payoutRatio": 0.0, "beta": 0.945, "forwardPE": 23.434021, "volume": 1101261, "regularMarketVolume": 1101261, "averageVolume": 2393419, "averageVolume10days": 1885090, "averageDailyVolume10Day": 1885090, "bid": 5.15, "ask": 9.1, "bidSize": 2, "askSize": 2, "marketCap": 1222861952, "fiftyTwoWeekLow": 3.14, "fiftyTwoWeekHigh": 10.08, "allTimeHigh": 27.98, "allTimeLow": 0.97, "priceToSalesTrailing12Months": 4.594859, "fiftyDayAverage": 7.809, "twoHundredDayAverage": 6.30435, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1388918016, "profitMargins": -0.058769997, "floatShares": 158762997, "sharesOutstanding": 165924289, "sharesShort": 15434811, "sharesShortPriorMonth": 15746194, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.093, "heldPercentInsiders": 0.03871, "heldPercentInstitutions": 0.59543, "shortRatio": 7.55, "shortPercentOfFloat": 0.0967, "impliedSharesOutstanding": 165924289, "bookValue": -0.005, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -15640000, "trailingEps": -0.1, "forwardEps": 0.3145, "enterpriseToRevenue": 5.219, "enterpriseToEbitda": 49.541, "52WeekChange": 1.1804733, "SandP52WeekChange": 0.17318606, "quoteType": "EQUITY", "currentPrice": 7.37, "targetHighPrice": 18.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.14286, "targetMedianPrice": 10.0, "recommendationKey": "none", "numberOfAnalystOpinions": 7, "totalCash": 91598000, "totalCashPerShare": 0.552, "ebitda": 28036000, "totalDebt": 257654000, "quickRatio": 1.251, "currentRatio": 1.928, "totalRevenue": 266136992, "revenuePerShare": 1.704, "returnOnAssets": 0.02875, "grossProfits": 225036992, "freeCashflow": 28553500, "operatingCashflow": 10558000, "revenueGrowth": 0.371, "grossMargins": 0.84556997, "ebitdaMargins": 0.105340004, "operatingMargins": 0.09049, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1766796695, "regularMarketTime": 1766782800, "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": 1.628221, "postMarketPrice": 7.49, "postMarketChange": 0.119999886, "regularMarketChange": 0.16, "regularMarketDayRange": "7.19 - 7.535", "fullExchangeName": "NasdaqGS", "regularMarketChangePercent": 2.21914, "regularMarketPrice": 7.37, "marketState": "CLOSED", "averageDailyVolume3Month": 2393419, "fiftyTwoWeekLowChange": 4.2299995, "fiftyTwoWeekLowChangePercent": 1.3471335, "fiftyTwoWeekRange": "3.14 - 10.08", "fiftyTwoWeekHighChange": -2.71, "fiftyTwoWeekHighChangePercent": -0.26884922, "fiftyTwoWeekChangePercent": 118.04733, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.1, "epsForward": 0.3145, "epsCurrentYear": 0.063, "priceEpsCurrentYear": 116.98412, "fiftyDayAverageChange": -0.43900013, "fiftyDayAverageChangePercent": -0.0562172, "twoHundredDayAverageChange": 1.06565, "twoHundredDayAverageChangePercent": 0.16903408, "priceToBook": -1474.0, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-12-26", "cryptoTradeable": false, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]